Ad is loading...
RLAY
Price
$5.11
Change
-$0.49 (-8.75%)
Updated
Nov 15 closing price
95 days until earnings call
RZLT
Price
$5.29
Change
-$0.31 (-5.54%)
Updated
Nov 15 closing price
80 days until earnings call
Ad is loading...

RLAY vs RZLT

Header iconRLAY vs RZLT Comparison
Open Charts RLAY vs RZLTBanner chart's image
Relay Therapeutics
Price$5.11
Change-$0.49 (-8.75%)
Volume$1.93M
CapitalizationN/A
Rezolute
Price$5.29
Change-$0.31 (-5.54%)
Volume$441.41K
CapitalizationN/A
RLAY vs RZLT Comparison Chart
Loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
RLAY vs. RZLT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Sell and RZLT is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (RLAY: $5.11 vs. RZLT: $5.29)
Brand notoriety: RLAY and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 98% vs. RZLT: 111%
Market capitalization -- RLAY: $854.49M vs. RZLT: $295.86M
RLAY [@Biotechnology] is valued at $854.49M. RZLT’s [@Biotechnology] market capitalization is $295.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileRZLT’s FA Score has 0 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • RZLT’s FA Score: 0 green, 5 red.
According to our system of comparison, RZLT is a better buy in the long-term than RLAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 4 TA indicator(s) are bullish while RZLT’s TA Score has 3 bullish TA indicator(s).

  • RLAY’s TA Score: 4 bullish, 4 bearish.
  • RZLT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than RZLT.

Price Growth

RLAY (@Biotechnology) experienced а -17.66% price change this week, while RZLT (@Biotechnology) price change was -5.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

RLAY is expected to report earnings on Feb 20, 2025.

RZLT is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($854M) has a higher market cap than RZLT($296M). RZLT YTD gains are higher at: 432.998 vs. RLAY (-53.633). RZLT has higher annual earnings (EBITDA): -57.32M vs. RLAY (-367.86M). RLAY has more cash in the bank: 688M vs. RZLT (13.2M). RZLT has less debt than RLAY: RZLT (2.37M) vs RLAY (51.1M). RLAY has higher revenues than RZLT: RLAY (35.2M) vs RZLT (0).
RLAYRZLTRLAY / RZLT
Capitalization854M296M289%
EBITDA-367.86M-57.32M642%
Gain YTD-53.633432.998-12%
P/E RatioN/AN/A-
Revenue35.2M0-
Total Cash688M13.2M5,212%
Total Debt51.1M2.37M2,155%
FUNDAMENTALS RATINGS
RZLT: Fundamental Ratings
RZLT
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLAYRZLT
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 17 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAGHX99.37-0.21
-0.21%
Permanent Portfolio Aggressive Growth C
LMEAX17.39-0.10
-0.57%
Franklin International Equity A
PGLEX15.83-0.14
-0.88%
Putnam Focused International Equity R6
PRVIX59.73-0.56
-0.93%
T. Rowe Price Small-Cap Value I
OSCYX24.06-0.33
-1.35%
Invesco Main Street Small Cap Y

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-8.84%
XNCR - RLAY
56%
Loosely correlated
-1.83%
BCYC - RLAY
46%
Loosely correlated
-3.50%
TVTX - RLAY
45%
Loosely correlated
-4.06%
PGEN - RLAY
45%
Loosely correlated
-7.11%
ABOS - RLAY
45%
Loosely correlated
-8.05%
More

RZLT and

Correlation & Price change

A.I.dvisor tells us that RZLT and RLAY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RZLT and RLAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
-5.54%
RLAY - RZLT
32%
Poorly correlated
-8.84%
EDSA - RZLT
27%
Poorly correlated
-4.55%
URGN - RZLT
27%
Poorly correlated
-5.65%
ABEO - RZLT
25%
Poorly correlated
-1.51%
VINC - RZLT
24%
Poorly correlated
-1.57%
More